eBioMedicine in conversation with
The Lancet Group
Editors of eBioMedicine and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
Episodes
John Cryan on the microbiome-gut-brain axis and binge drinkingJuly 25, 2023
Alvaro Berbís & David McClintock on computational pathology in 2030May 04, 2023
Peter Robinson and Justin Reese on Long COVID subtypesFebruary 24, 2023
Ke-Wu Zeng on molecular glues for cancer therapyJanuary 18, 2023
Elke Fischer & Thomas Horvatits on microplastics in human tissuesSeptember 12, 2022
Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDSJuly 19, 2022
Matthieu Pernot, Clément Papadacci & Alexandre Dizeux on brain imaging and scientific commsJune 15, 2022
Lilian Hunt on diversity in medical researchApril 22, 2022
Jun Seok Son and Min Du on maternal exercise and offspring healthMarch 18, 2022
Marc Mansour and Victor Llombart on MYC in cancerFebruary 18, 2022
Rachel Deer on long COVIDJanuary 18, 2022
James Zou & David Ouyang on deep learning and hidden clinical correlatesDecember 22, 2021
Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICsDecember 14, 2021
Anthony Chirwa and Ben Morton on the importance of localised researchNovember 16, 2021
Jodi Sherman on the intersection between healthcare and climate changeOctober 27, 2021
Grace Fox and Dr Manoj Lalu on the importance of patient engagement in preclinical researchSeptember 22, 2021
Aleix Prat on chemotherapy and menopauseAugust 04, 2021
Viviana Simon and Maria Rescigno on mRNA vaccine dosing after prior infectionJune 29, 2021